pRL-TK 4x wt Citations (4)

Originally described in: Specificity of microRNA target selection in translational repression.
Doench JG, Sharp PA Genes Dev. 2004 Mar 1. 18(5):504-11. PubMed Journal

---

Articles Citing pRL-TK 4x wt

Articles
TNFRSF19 within the 13q12.12 Risk Locus Functions as a Lung Cancer Suppressor by Binding Wnt3a to Inhibit Wnt/beta-Catenin Signaling. Zuo X, Wang X, Ma T, Chen S, Cao P, Cheng H, Yang N, Han X, Gao W, Liu X, Sun Y. Mol Cancer Res. 2024 Mar 1;22(3):227-239. doi: 10.1158/1541-7786.MCR-23-0109. PubMed
PAX6 promotes neuroendocrine phenotypes of prostate cancer via enhancing MET/STAT5A-mediated chromatin accessibility. Jing N, Du X, Liang Y, Tao Z, Bao S, Xiao H, Dong B, Gao WQ, Fang YX. J Exp Clin Cancer Res. 2024 May 15;43(1):144. doi: 10.1186/s13046-024-03064-1. PubMed
RUVBL1/2 Blockade Targets YTHDF1 Activity to Suppress m6A-Dependent Oncogenic Translation and Colorectal Tumorigenesis. Chen D, Ji F, Zhou Q, Cheung H, Pan Y, Lau HC, Liang C, Yang Z, Huang P, Wei Q, Cheung AH, Kang W, Chen H, Yu J, Wong CC. Cancer Res. 2024 Sep 4;84(17):2856-2872. doi: 10.1158/0008-5472.CAN-23-2081. PubMed
HIF-1alpha induced FGF18 alleviates renal ischemia/reperfusion injury via YAP. Wang N, Huang Z, Guan F, Wang J, Chen Y, Wang H, Jin L, Wang Y. FASEB J. 2024 Oct 15;38(19):e70092. doi: 10.1096/fj.202401238R. PubMed

If you have published an article using this material, please email us at to have your article added to this page.